Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

10.09.2018 / 12:44
The issuer is solely responsible for the content of this announcement.

1. Details of the person discharging managerial responsibilities / person closely associated

a) Name
Name and legal form: Armin M. Kessler and Ann C. Kessler Family Trust

2. Reason for the notification

a) Position / status
Person closely associated with:
Title:
First name: Ann Clare
Last name(s): Kessler
Position: Member of the administrative or supervisory body

b) Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name
Epigenomics AG

b) LEI
549300X1C4U862NDLN97 

4. Details of the transaction(s)

a) Description of the financial instrument, type of instrument, identification code
Type: Share
Description: Share ISIN DE000A11QW50 Epigenomics American Depositary Receipt (under Sponsored Level 1 Epigenomics-ADR Program) ISIN US29428N1028

b) Nature of the transaction
Conversion of 2,201 Epigenomics American Depositary Receipts acquired on June 11, 2018 (under Sponsored Level 1 Epigenomics-ADR Program) with an aggregated volume of 39,992.17 USD at a ratio of five ordinary shares to one Epigenomics ADR into 11,005 ordinary shares of Epigenomics AG

c) Price(s) and volume(s)
Price(s) Volume(s)
18.17 USD 39992.17 USD

d) Aggregated information
Price Aggregated volume
18.17 USD 39992.17 USD

e) Date of the transaction
2018-06-14; UTC-4

f) Place of the transaction
Outside a trading venue


10.09.2018 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de

Language: English
Company: Epigenomics AG
Geneststraße 5
10829 Berlin
Germany
Internet: www.epigenomics.com

 
End of News DGAP News Service

44687  10.09.2018